Jonathan Wosen from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug - 3 days ago Study of gender-affirming care reveals immune system sex differences - 12 days ago STAT+: Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate - 25 days ago Teamwork is good for science — but maybe not for young researchers’ careers - 27 days ago STAT+: Pharmalittle: We’re reading about a soft-tissue cancer drug approval, the Zepbound shortage ending, and more - about 2 months ago Expansive new study points to distinct brain networks linked to sex and gender - 2 months ago STAT+: Cassava Sciences collaborator charged with defrauding NIH in grants supporting its Alzheimer’s drug - 3 months ago STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test - 4 months ago STAT+: About half of cancer drugs given accelerated approval don’t show improved survival or quality of life - 5 months ago STAT+: Cancer is rising among the young. Study suggests it’s because their cells are aging faster - 5 months ago STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves - 7 months ago STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit - 7 months ago STAT+: Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi - 9 months ago Allen Institute CEO Rui Costa on mapping the brain and paying early-career scientists decent salaries - 9 months ago NIH panel calls for fewer, better-paid postdocs in bid to halt loss of scientists to industry - 9 months ago STAT+: Vertex non-opioid drug reduces chronic nerve pain in mid-stage study - 9 months ago STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease - 9 months ago STAT+: Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug - 9 months ago STAT+: Inside Vertex’s decades-long quest to develop a new class of non-opioid painkillers - 9 months ago STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH - 9 months ago STAT+: With biotech in a slump, the industry’s job market is upside down - 10 months ago Pharmalittle: European patent agency invalidates a Moderna mRNA patent; pharma ally Eshoo plans to retire - 10 months ago STAT+: Life scientists’ flight to biotech labs stalls important academic research - 10 months ago Rats have an imagination, too, researchers show with brain implants - 11 months ago STAT+: FDA approves Lilly ulcerative colitis treatment with a new approach to tamping down inflammation - 11 months ago STAT+: Biotech power broker John Maraganore offers advice to the next crop of entrepreneurs - 11 months ago STAT+: Cell and gene therapy CEOs share survival strategies amid biotech slump - 11 months ago STAT+: Scientists have mapped the human brain in unprecedented detail. They’re just getting started - 11 months ago STAT+: Neurocrine reports second late-stage trial success for congenital adrenal hyperplasia drug - 12 months ago STAT+: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise - 12 months ago STAT+: Pharmalittle: End of biotech’s stock market malaise may be near; cancer drug shortages hit rural clinics hard - 12 months ago STAT+: Biotech lab-space demand falls sharply as industry’s ‘sugar high’ turns into a ‘reset’ - 12 months ago
2	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test - 4 months ago STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves - 7 months ago STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit - 7 months ago
3	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Vertex non-opioid drug reduces chronic nerve pain in mid-stage study - 9 months ago
4	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	STAT+: With biotech in a slump, the industry’s job market is upside down - 10 months ago